ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium
TORONTO, ON / ACCESSWIRE / December 6, 2024 / ProteinQure, the leading company in computational design of peptide therapeutics, will be presenting compelling new data on the progress of their lead triple negative breast cancer (TNBC) drug PQ203 (December 12, 2024 presentation ID: P4-12-17) at the 2024 San Antonio Breast Cancer Symposium.
PQ203 is a novel Peptide Drug Conjugate composed of a Sortilin receptor targeting peptide conjugated to the cytotoxic agent monomethyl auristatin E. The Sortiin receptor is expressed in a high percentage of diseased tissue from TNBC patients and as such represents an innovative treatment for this challenging sub-type of breast cancer.
ProteinQure has recently generated data that PQ203 exhibits potent efficacy in a patient-derived xenograft (PDX) model resistant to Sacituzumab Govitecan (Trodelvy™), an antibody drug conjugate that is the emerging standard of care for metastatic TNBC. Additionally, PQ203 has shown an encouraging safety profile. Based on these findings as well as earlier in vivo efficacy studies, ProteinQure has initiated GLP-toxicology studies for PQ203 in support of an anticipated investigational new drug application filing in Q2 of 2025.
"These combined findings confirm the power of our computational drug design platform and its potential to address key challenges in cancer therapy. We are deeply committed to moving PQ203 forward and are eager to bring this innovative treatment to clinical trials." stated Lucas Siow, CEO of ProteinQure.
Phase 1a/b trial initiation for PQ203 is planned for the second half of 2025 and will be coordinated at the Princess Margaret Cancer Center in Toronto and other leading hospitals in North America.
For media inquiries please contact Lucas Siow at lucas@proteinqure.com
SOUCE: ProteinQure Inc.
View the original press release on accesswire.com
ProteinQure Inc.
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
The Now Corporation's (OTC:NWPN) Subsidiary, Green Rain Solar Inc., Targets Southwest Expansion with EV Charging and Community Solar Initiatives24.1.2025 08:00:00 CET | Press release
PASADENA, CA / ACCESS Newswire / January 24, 2025 / The Now Corporation (OTC PINK:NWPN) is excited to announce that its wholly-owned subsidiary, Green Rain Solar Inc., is preparing to establish a significant presence in the Southwest, focusing on the New Mexico and Arizona markets. The company plans to collaborate with channel partners to drive the adoption of solar-powered electric vehicle (EV) charging stations, a pivotal step in its commitment to delivering innovative and sustainable energy solutions. In anticipation of this expansion, Green Rain Solar has already registered with the Secretaries of State in both Arizona and New Mexico. The company's long-term vision includes integrating solar energy into EV infrastructure while addressing the energy needs of high-cost urban areas across the region. To further its growth strategy, Green Rain Solar is relocating its West Coast regional offices to New Mexico. The move reflects the company's confidence in the state's vast solar energy p
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union24.1.2025 06:30:00 CET | Press release
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS Newswire / January 24, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years. "This agreement presents an opportunity for Moderna to support and strengthen national COVID-19 vaccination campaigns across participating countries," said Chantal Friebertshäuser, Senior Vice President, General Manager - Europe & Middle-East, Moderna. "Diversity of supply and availability of vaccine formats such as pre-filled syringes are vital to help increase vaccination rates and enhance vaccination campaign efficiency, ultimately strengthening health security." Under
Photonis Launches Two Market-Leading Solutions to Advance Single Photon Detection and Imaging Applications23.1.2025 09:00:00 CET | Press release
Advancing Photon Detection and Imaging: Photonis Unveils Cricket™ Pro and PhotonPix™ SAN FRANCISCO, CA / ACCESS Newswire / January 23, 2025 / Photonis, a leading brand of Exosens and global leader in advanced photon detection and imaging solutions, proudly announces the launch of Cricket™ Pro and PhotonPix™. Designed to redefine the possibilities of single photon detection and imaging, these cutting-edge solutions empower researchers and industry professionals to achieve unparalleled performance across applications such as biomedical imaging, quantum science, and high-energy physics.Cricket Pro and PhotonPix These technologies will officially debut at SPIE Photonics West 2025 in San Francisco, CA. Cricket™ Pro: Transforming Low-Light Imaging with High-Speed Precision The Cricket™ Pro brings unprecedented imaging capabilities for low-light and single-photon imaging applications. This innovative, plug-and-play image intensifier adapter easily fits any professional, scientific, F-Mount ca
U.S. Polo Assn. Celebrates the 2025 United States Winter Polo Season as Official Sponsor of the USPA National Polo Center (NPC)23.1.2025 07:00:00 CET | Press release
WEST PALM BEACH, FLORIDA / ACCESS Newswire / January 23, 2025 / U.S. Polo Assn., the official brand of the United States Polo Association (USPA), celebrates the 2025 United States Winter Polo Season and the 135th Anniversary of the USPA, as the Official Sponsor of the USPA National Polo Center (NPC). Along with that distinction comes exclusive naming rights to Field One as the U.S. Polo Assn. Stadium Field, Field One's game scoreboard, and Field Two signage. Regarded as one of the world's premier facilities for the sport of polo, NPC features even more new and exciting branded updates for the thousands of fans who will visit this world-class destination in 2025. The USPA National Polo Center and U.S. Polo Assn. are proud to unveil new navy and white sponsorship signage surrounding the U.S. Polo Assn. Stadium Field, an expanded asado grill area for pregame food and beverage with U.S. Polo Assn. lounge chairs, as well as exciting updates to the U.S. Polo Assn. MVP Lounge. Located in the
The Now Corporation (OTC:NWPN) In Conjunction With Subsidiary Green Rain Solar Inc., Launch a Visionary Video Showcasing Solar Energy Solutions23.1.2025 00:00:00 CET | Press release
PASADENA, CA / ACCESS Newswire / January 23, 2025 / The Now Corporation (OTC PINK:NWPN) and its subsidiary, Green Rain Solar Inc., are proud to unveil an inspiring video that highlights their mission to revolutionize urban solar energy solutions. The video, available on YouTube, provides an engaging glimpse into how Green Rain Solar Inc. is transforming rooftops into sustainable energy hubs that seamlessly integrate with the grid. The video, accessible here: https://ai.invideo.io/watch/jVS2cWk9mbP, takes viewers on a journey through Green Rain Solar Inc.'s innovative approach to addressing energy demands in urban environments. As cities face rising energy costs and growing environmental challenges, Green Rain Solar Inc. offers a groundbreaking solution by turning unused rooftop space into a renewable energy source. Alfredo Papadakis, CEO of The Now Corporation, stated: "This video serves as a powerful medium to communicate our vision and the critical role Green Rain Solar Inc. plays in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom